Radical therapy for muscle-infiltrating bladder cancer (cystectomy or radiotherapy): does age affect the final therapeutic benefit for the patient?

Απλή σελίδα τεκμηρίου
dc.contributor.authorKalogeras, D.en
dc.contributor.authorLampri, E.en
dc.contributor.authorGoussia, A.en
dc.contributor.authorBai, M.en
dc.contributor.authorCapizzello, A.en
dc.contributor.authorTassiou, I.en
dc.contributor.authorStavropoulos, N. E.en
dc.contributor.authorTsekeris, P.en
dc.date.accessioned2015-11-24T18:38:09Z
dc.date.available2015-11-24T18:38:09Z
dc.identifier.issn1107-0625-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/17288
dc.rightsDefault Licence-
dc.subjectageen
dc.subjectbladder canceren
dc.subjectcystectomyen
dc.subjectmuscle-infiltratingen
dc.subjectradiotherapyen
dc.subjectsurvivalen
dc.subjecttransitional-cell carcinomaen
dc.subjectileal conduit diversionen
dc.subjectterm-follow-upen
dc.subjectneoadjuvant chemotherapyen
dc.subjectsurvivalen
dc.subjectpreservationen
dc.subjectcomplicationsen
dc.subjectmetastasesen
dc.subjectradiationen
dc.subjectprostateen
dc.titleRadical therapy for muscle-infiltrating bladder cancer (cystectomy or radiotherapy): does age affect the final therapeutic benefit for the patient?en
heal.abstractPurpose: To evaluate the therapeutic outcome of radical cystectomy and radical radio therapy in patients with T2N0M0 clinical stage bladder cancer in relation to their age. Patients and methods: Between 1995-2006, 119 patients with clinical stage T2N0M0 bladder cancer were treated with radical radiotherapy (group A) and were divided in 2 subgroups: > 70 years old(A1) and <= 70 years old (A2). Between 1998-2006, 26 patients with the same clinical stage were treated with radical cystectomy (group B) (> 70 years old/B1 subgroup and <= 70 years old/B2 subgroup). The following parameters were evaluated in both groups and subgroups: therapeutic outcome (overall survival/OS, local control, development of metastases) and tolerance (side effects and complications of each method). Kaplan-Meier method and log-rank test were used for statistical analyses. Results: All group B patients tolerated their treatment very well, without interruptions. The 3-year OS of groups A and B was 39 and 69%, respectively (p= 0.032). The 3-year OS of subgroups A I and A 2 was 37.3 and 43.3%, respectively (p= 0.085). In the cystectomy group B, 3-year OS of the subgroups was the same (B1: 68.6% and B2: 69.3%; p= 0.10). Local control rate for the subgroups A1, A2, B1, B2 was 43, 40, 90 and 84%, respectively. Distant metastatic rate was 14.1, 20, 7.6 and 7.4% for subgroups A1, A2, B1, B2, respectively. Conclusion: The results of both therapeutic methods in both age groups seem satisfactory. Very good tolerance was also observed. It seems that if a patient is not completely suitable for radical cystectomy or radical radiotherapy age should not be considered as an exclusion factor.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondary<Go to ISI>://000259689200006-
heal.journalNameJournal of Buonen
heal.journalTypepeer reviewed-
heal.languageen-
heal.publicationDate2008-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών και Τεχνολογιών. Τμήμα Βιολογικών Εφαρμογών και Τεχνολογιώνel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)